Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.5.2801

Association of ABO Blood Group and Risk of Lung Cancer in a Multicenter Study in Turkey  

Urun, Yuksel (Department of Medical Oncology, Ankara University School of Medicine)
Utkan, Gungor (Department of Medical Oncology, Ankara University School of Medicine)
Cangir, Ayten Kayi (Department of Thoracic Surgery, Ankara University School of Medicine)
Oksuzoglu, Omur Berna (Department of Medical Oncology, Dicle University Faculty of Medicine)
Ozdemir, Nuriye (Department of Medical Oncology, Dicle University Faculty of Medicine)
Oztuna, Derya Gokmen (Department of Biostatistics, Ankara University School of Medicine)
Kocaman, Gokhan (Department of Thoracic Surgery, Ankara University School of Medicine)
Coskun, Hasan Senol (Department of Medical Oncology, Dicle University Faculty of Medicine)
Kaplan, Muhammet Ali (Department of Medical Oncology, Dicle University Faculty of Medicine)
Yuksel, Cabir (Department of Thoracic Surgery, Ankara University School of Medicine)
Demirkazik, Ahmet (Department of Medical Oncology, Ankara University School of Medicine)
Icli, Fikri (Department of Medical Oncology, Ankara University School of Medicine)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.5, 2013 , pp. 2801-2803 More about this Journal
Abstract
Background: The ABO blood groups and Rh factor may affect the risk of lung cancer. Materials and Methods: We analyzed 2,044 lung cancer patients with serologically confirmed ABO/Rh blood group. A group of 3,022,883 healthy blood donors of Turkish Red Crescent was identified as a control group. We compared the distributions of ABO/Rh blood group between them. Results: The median age was 62 years (range: 17-90). There was a clear male predominance (84% vs. 16%). Overall distributions of ABO blood groups were significantly different between patients and controls (p=0.01). There were also significant differences between patients and controls with respect to Rh positive vs. Rh negative (p=0.04) and O vs. non-O (p=0.002). There were no statistically significant differences of blood groups with respect to sex, age, or histology. Conclusions: In the study population, ABO blood types were associated with the lung cancer. Having non-O blood type and Rh-negative feature increased the risk of lung cancer. However, further prospective studies are necessary to define the mechanisms by which ABO blood type may influence the lung cancer risk.
Keywords
ABO blood; group system; lung neoplasms; cancer; risk factors;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Ahlbrecht J, Dickmann B, Ay C, et al (2012). Tumor grade is associated with venous thromboembolism in patients with cancer: results from the vienna cancer and thrombosis study. J Clin Oncol, 30, 3870-5.   DOI   ScienceOn
2 Alvarez-Fernandez E, Carretero-Albinana L (1991). Expression of blood group antigens by normal bronchopulmonary tissues and common forms of pulmonary carcinomas. Arch Pathol Lab Med, 115, 42-9.
3 Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, et al (2009). Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet, 41, 986-90.   DOI   ScienceOn
4 Bowen DJ (2003). An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13. J Thromb Haemost, 1, 33-40.   DOI   ScienceOn
5 Cerny T, Fey MF, Oppliger R, et al (1992). Prevalence of the Rhesus-negative phenotype in Caucasian patients with smallcell lung cancer (SCLC). Int J Cancer, 52, 504-6.   DOI
6 Chew HK, Davies AM, Wun T, et al (2008). The incidence of venous thromboembolism among patients with primary lung cancer. J Thromb Haemost, 6, 601-8.   DOI   ScienceOn
7 Chew HK, Wun T, Harvey D, Zhou H, White RH (2006). Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med, 166, 458-64.   DOI
8 Chew HK, Wun T, Harvey DJ, Zhou H, White RH (2007). Incidence of venous thromboembolism and the impact on survival in breast cancer patients. J Clin Oncol, 25, 70-6.
9 Cohen W, Castelli C, Alessi MC, et al (2012). ABO blood group and von Willebrand factor levels partially explained the incomplete penetrance of congenital thrombophilia. Arterioscler Thromb Vasc Biol, 32, 2021-8.   DOI   ScienceOn
10 Couraud S, Zalcman G, Milleron B, Morin F, Souquet PJ (2012). Lung cancer in never smokers--a review. Eur J Cancer, 48, 1299-311.   DOI   ScienceOn
11 Dela Cruz CS, Tanoue LT, Matthay RA (2011). Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med, 32, 605-44.   DOI
12 Edgren G, Hjalgrim H, Rostgaard K, et al (2010). Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol, 172, 1280-5.   DOI   ScienceOn
13 Graziano SL, Tatum AH, Gonchoroff NJ, Newman NB, Kohman LJ (1997). Blood group antigen A and fl ow cytometric analysis in resected early-stage non-small cell lung cancer. Clin Cancer Res, 3, 87-93.
14 Humphray SJ, Oliver K, Hunt AR, et al (2004). DNA sequence and analysis of human chromosome 9. Nature, 429, 369-74.   DOI   ScienceOn
15 Gwin JL, Klein-Szanto AJ, Zhang SY, et al (1994). Loss of blood group antigen A in non-small cell lung cancer. Ann Surg Oncol, 1, 423-7.   DOI
16 Hakomori S (2001). Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anticancer vaccines. Adv Exp Med Biol, 491, 369-402.   DOI
17 Heit JA, Armasu SM, Asmann YW, et al (2012). A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q. J Thromb Haemost, 10, 1521-31.   DOI   ScienceOn
18 Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.   DOI
19 Joh HK, Cho E, Choueiri TK (2012). ABO blood group and risk of renal cell cancer. Cancer Epidemiol, 36, 528-32.   DOI   ScienceOn
20 Lee JS, Ro JY, Sahin AA, et al (1991). Expression of blood-group antigen A--a favorable prognostic factor in non-small-cell lung cancer. N Engl J Med, 324, 1084-90.   DOI   ScienceOn
21 Leon-Atance P, Moreno-Mata N, Gonzalez-Aragoneses F, et al (2012). Prognostic influence of loss of blood group A antigen expression in pathologic stage I non-small-cell lung cancer. Arch Bronconeumol, 48, 49-54.
22 Miyake M, Taki T, Hitomi S, Hakomori S (1992). Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung. N Engl J Med, 327, 14-8.   DOI   ScienceOn
23 Poole EM, Gates MA, High BA, et al (2012). ABO blood group and risk of epithelial ovarian cancer within the ovarian cancer association consortium. Cancer Causes Control, 23, 1805-10.   DOI
24 Ulger AF, Keklik T, Kumbasar OO, et al (2002). Prognostic significance of blood group antigen expression of tumor tissue in lung cancer patients. Tumori, 88, 395-9.
25 Rice TW, Tubbs RR, Hoeltge GA, et al (1995). Expression of blood group antigen A by stage I non-small cell lung carcinomas. Ann Thorac Surg, 59, 568-72.   DOI   ScienceOn
26 Sanchez-Mora N, Cebollero PM, Monroy V, Herranz AM, Alvarez-Fernandez E (2007). Expression of histo-blood group antigens in bronchial squamous metaplasia. Eur Respir J, 29, 268-72.
27 Suadicani P, Hein HO, Gyntelberg F (2007). ABO phenotypes and inflammation-related predictors of lung cancer mortality: the Copenhagen Male Study - a 16-year follow-up. Eur Respir J, 30, 13-20.   DOI   ScienceOn
28 Urun Y, Ozdemir NY, Utkan G, et al (2012). ABO and Rh blood groups and risk of colorectal adenocarcinoma. Asian Pac J Cancer Prev, 13, 6097-100.   DOI   ScienceOn
29 Wolpin BM, Chan AT, Hartge P, et al (2009). ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst, 101, 424-31.   DOI   ScienceOn
30 Wu O, Bayoumi N, Vickers MA, Clark P (2008). ABO(H) blood groups and vascular disease: a systematic review and metaanalysis. J Thromb Haemost, 6, 62-9.
31 Xie J, Qureshi AA, Li Y, Han J (2010). ABO blood group and incidence of skin cancer. PLoS One, 5, 11972.   DOI   ScienceOn